Filing Flows › BioScience Health Innovations (BHIC) › Q1 2025
BioScience Health Innovations (BHIC) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
BioScience Health Innovations (BHIC) reported revenue of $1.2M for the first quarter 2025 (Q1 2025), +342% from a year earlier and +101% from the quarter before. Operating margin was 34.8%, net earnings $427K (34.8% of revenue).
BioScience Health Innovations, Q1 2025: revenue $1.2M (+342% year over year), operating margin 34.8%, net earnings $427K, operating cash flow $328K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | +101% | +342% |
| Gross profit | $896K | +164% | +282% |
| Operating profit | $427K | 43× | — |
| Net earnings | $427K | 43× | — |
| Operating cash flow | $328K | — | — |
What changed
Revenue was $1.2M in Q1 2025, up 342% year over year and up 101% from the previous quarter.
Gross margin was 73.0%, down 11.5 points from a year earlier. Operating profit was $427K, a 34.8% margin (up 54.0 points year over year). Operating expenses grew 63% against revenue growth of 342%. Net earnings were $427K. The effective tax rate was 0.0%.
Operating cash flow was $328K, 77% of net earnings. Working capital and other items used $98K.
Questions
What was BioScience Health Innovations' revenue in the first quarter 2025?
BioScience Health Innovations (BHIC) reported revenue of $1.2M for the first quarter 2025 (Q1 2025), +342% from a year earlier and +101% from the quarter before.
Was BioScience Health Innovations profitable in the first quarter 2025?
Operating profit was $427K (34.8% of revenue) and net earnings $427K.